MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Dyskinesia profiles after dose challenges with L-dopa vs L-dopa plus ropinirole: a pilot study

    S. Grigoriou, P. Odin, E. Espa, A. Cenci (Lund, Sweden)

    Objective: To investigate possible differences in the profiles of abnormal involuntary movements (AIMs) in patients with Parkinson’s disease (PD) after dose challenge with L-dopa alone…
  • 2022 International Congress

    A role of β2-adrenoreceptor agonist related to the development of Parkinson’s disease

    WW. Lee (Seoul, Republic of Korea)

    Objective: To explore β2AR agonist’s effect on PD development with controlling for smoking. Background: Several studies have suggested the potential protective role of β2-adrenoreceptor agonist (β2AR…
  • 2022 International Congress

    Impaired Imagery of Tremor in Patients with Essential Tremor

    K. Steidel, A R. Abou Watfa, C. Nelles, E. Pelzer, M. Tittgemeyer, L. Timmermann, DJ. Pedrosa (Marburg, Germany)

    Objective: To investigate neural mechanisms underlying motor imagination (MI) in essential tremor (ET) patients compared to healthy controls using high-density EEG. Background: ET ranges among…
  • 2022 International Congress

    Differential temporal dynamics of axial and appendicular ataxia in SCA3

    R. Maas, S. Teerenstra, M. Lima, P. Pires, L. Pereira, J. van Gaalen, D. Timmann, J. Infante, C. Onyike, K. Bushara, H. Jacobi, K. Reetz, M. Santana, J. Ribeiro, J. Hübener-Schmid, J. de Vries, M. Synofzik, L. Schöls, H. Garcia-Moreno, P. Giunti, J. Faber, T. Klockgether, B. Vande Warrenburg (Nijmegen, Netherlands)

    Objective: To investigate the temporal dynamics of Scale for the Assessment and Rating of Ataxia (SARA) item scores in patients with spinocerebellar ataxia type 3…
  • 2022 International Congress

    Case reports of first experiences worldwide with novel continuous oral levodopa dental pump in Parkinson’s Disease Patients

    D. Mcintyre, O. Terwindt, L. Pavelka, G. Schilling, A. Znati, L. Skhiri, M. Gantenbein, E. Heller, A. Heller, J. Kennedy, J. Harmon, C. Kamp, M. Torti, CW. Olanow, R. Krueger (Strassen, Luxembourg)

    Objective: To assess the safety, tolerability, and pharmacokinetics (PK) of a novel continuous levodopa-carbidopa oral pump (LCOP) delivery system in patients with early PD. Background:…
  • 2022 International Congress

    Exploring the impact of central cholinergic dysfunction on cognitive functioning in patients of Parkinson’s disease with and without REM sleep behavior disorder

    A. Bhattacharya, K. Udupa, N. Kamble, M. Gothwal, S. Hegde, R. Yadav, PK. Pal (Bengaluru, India)

    Objective: This paper aims at establishes the presence of significantly higher cholinergic dysfunction in patients using short latency afferent inhibition. Background: Parkinson's disease (PD) is…
  • 2022 International Congress

    The impact of thyroid disease on severity of motor symptoms in Croatian residents with de novo Parkinson’s disease

    I. Sarac, H. Sarac, F. Borovecki, I. Ivek, L. Bagaric Krakan, Z. Kresic, M. Iveta, T. Sukobljevic (Zagreb, Croatia)

    Objective: The goal of this study was to investigate the association between thyroid disease and severity of motor symptoms in Croatian residents with de novo…
  • 2022 International Congress

    Transauricular Vagus Nerve Stimulation (taVNS) for mild to moderate Parkinson’s Disease (PD)

    V. Hinson, C. Mcleod, B. Badran, H. Boger, L. Lovera, A. Phan, J. Elm, T. Turner (Charleston, USA)

    Objective: We evaluated feasibility, safety, and preliminary efficacy of taVNS for motor and non-motor symptoms in mild to moderate PD. Background: Neuronal loss in the…
  • 2022 International Congress

    Synaptic density in cortical and subcortical gray matter is associated with mild parkinsonian signs (MPS) in healthy older adults: a [11C] UCB-J PET study

    M. van Cauwenberge, A. Delva, T. Vande Casteele, A. Radwan, M. Laroy, K. van Laere, S. Sunaert, J. Vanden Stock, F. Bouckaert, L. Emsell, W. Vandenberghe, M. Vandenbulcke (Leuven, Belgium)

    Objective: to investigate if a reduction in cortical and subcortical synaptic density measured in vivo with the synaptic vesicle protein 2A (SV2A) binding [11C] UCB-J…
  • 2022 International Congress

    Cognitive performances and autonomic dysfunction in MSA patients

    G. Lazzeri, A. Carandina, T. Di Fonzo, F. Arienti, E. Monfrini, I. Trezzi, G. Franco, E. Tobaldini, A. Di Fonzo (Milan, Italy)

    Objective: This study aims to assess the cardiovascular autonomic profile in patients suffering from either MSA-P or MSA-C, and subsequently to explore a potential link…
  • « Previous Page
  • 1
  • …
  • 555
  • 556
  • 557
  • 558
  • 559
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley